Aims: To determine the positive predictive value (PPV) of cervical smear diagnoses of 'definite' and 'possible' endocervical adenocarcinoma in situ or invasive adenocarcinoma, and whether diagnostic accuracy can be improved.

Methods: The study examined cervical smears reported as definite or possible high-grade glandular abnormality between 1992 and 1998. PPV was calculated by comparing smear diagnoses with the subsequent histopathology report. All available smears were reviewed without knowledge of follow-up results, and were reclassified by consensus.

Results: Thirty-two smears were diagnosed as high-grade glandular lesions, with adequate biopsy follow-up in 31 cases (96.9%). A high-grade epithelial abnormality (HGEA) was detected in 29 cases (PPV, 93.5%), with a high-grade glandular lesion in 24 (PPV, 77.4%). Very few smears were reclassified on review. Seventy-three smears were initially diagnosed in the 'inconclusive' glandular or indeterminate cell-type category. There was adequate biopsy follow up for 54 cases (74.0%). On follow-up, 31 cases had a HGEA (PPV, 57.4%), with 14 cases having a high-grade glandular abnormality (PPV, 25.9%). In the review of 'inconclusive' smears, 12 were reclassified as squamous abnormalities and none of these had a glandular lesion on biopsy. Eight were reclassified as negative; seven contained endometrial stroma and the glandular cells in question were considered to be of lower uterine segment (LUS) origin. No significant lesion was present on follow-up of these cases.

Conclusions: For clinicians using our laboratory, large loop excision of the transformation zone (LLETZ) or cone biopsy should follow a 'definite' cytological diagnosis of a high-grade endocervical glandular lesion. However, cone biopsy may not be the appropriate initial management in the 'possible' high-grade glandular group because of a significantly lower predictive value of the diagnosis. The slide review highlighted the importance of (1) caution in classifying sheets of abnormal cells as glandular, and (2) endometrial stroma as a marker of LUS material.

Download full-text PDF

Source
http://dx.doi.org/10.1080/0031302031000123146DOI Listing

Publication Analysis

Top Keywords

high-grade glandular
20
glandular lesion
12
glandular
11
endocervical glandular
8
cervical smears
8
smear diagnoses
8
glandular abnormality
8
adequate biopsy
8
follow-up cases
8
smears reclassified
8

Similar Publications

P53-abnormal endometrial carcinomas are high-grade and aggressive tumors which should be treated with chemo-/radiotherapy. In low-grade endometrioid carcinoma (LGEC), abnormal expression of p53 is an exceptional finding and is typically accompanied by patchy p16 positivity and diffuse hormone receptor expression. Herein, we report a case of LGEC exhibiting both p53 and p16 overexpression, highlighting the diagnostic pitfalls related to such phenotype.

View Article and Find Full Text PDF

[Spiradenocarcinoma, cylindrocarcinoma and spiradenocylindrocarcinoma: a clinicopathological study of seven cases].

Zhonghua Bing Li Xue Za Zhi

December 2024

Department of Pathology, Shanghai Cancer Center, Fudan University and Department of Oncology, Shanghai medical College, Fudan University, Shanghai200032, China.

Article Synopsis
  • - This study analyzed the clinicopathological features of spiradenocarcinoma, cylindrocarcinoma, and spiradenocylindrocarcinoma using seven cases diagnosed at Fudan University Shanghai Cancer Center from 2015 to 2021, focusing on tumor characteristics and clinical behavior correlations.
  • - The tumors predominantly affected middle-aged individuals and were primarily located on the head and neck, extremities, and trunk; histopathological evaluations revealed types such as low-grade and high-grade basal cell adenocarcinoma-like patterns, along with invasive adenocarcinoma not otherwise specified (IAC-NOS), some containing mucinous components.
  • - Follow-up data indicated poor prognosis specifically for IAC-NOS cases, with
View Article and Find Full Text PDF

Objective: This study assessed the prevalence and factors associated with detecting cervical intraepithelial neoplasia grade 2 or higher (CIN2+) via endocervical curettage (ECC) during colposcopy.

Methods: Between December 2020 and September 2023, a prospective, cross-sectional study involving women with abnormal cervical cancer screening results who underwent colposcopy was conducted. ECC was performed via a Kevorkian endocervical curette following colposcopy-directed biopsy.

View Article and Find Full Text PDF

Primary prevention of cervical cancer is best achieved by vaccinating girls with a prophylactic human papillomavirus (HPV) vaccine. Despite the high efficacy of such vaccines, cervical cancer screening remains necessary because current vaccines do not offer full protection. Secondary prevention via cervical screening should target all women from age 25 years or at the onset of sexual activity, whichever occurs later, until age 64 years.

View Article and Find Full Text PDF
Article Synopsis
  • Divergent differentiation in urothelial carcinoma complicates accurate histopathological diagnosis, as traditional cancer features can be sparse, leading to potential oversights by inexperienced pathologists.
  • Recognizing this differentiation is vital not only for establishing a correct diagnosis and preventing the false reporting of rare tumors but also because it influences the classification of the cancer as high-grade, impacting patient treatment and management.
  • A case study of a male patient revealed a high-grade urothelial carcinoma with features resembling primarily colonic-type adenocarcinoma, showcasing the importance of identifying divergent differentiation to rule out metastasis from other organs.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!